OPL Expands Anticancer Portfolio

Expanding its operational capacity with a new solid dosage production line for anticancer drugs, Bangladesh-based Opsonin Pharma called on pharmaceutical equipment manufacturer, GEA Group, to supply the technology and expertise required for the contained handling of highly potent active ingredients.